1240970-58-4

Basic information

• Product Name: ethyl 1-(6-(2-hydroxy-3-(trifluoromethyl)phenyl)pyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate
• Synonyms: ethyl 1-(6-(2-hydroxy-3-(trifluoromethyl)phenyl)pyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate
• CAS NO: 1240970-58-4
• Molecular Weight: 445.321
• Mol File: 1240970-58-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: ethyl 1-(6-(2-hydroxy-3-(trifluoromethyl)phenyl)pyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 1-(6-(2-hydroxy-3-(trifluoromethyl)phenyl)pyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate(1240970-58-4)
• EPA Substance Registry System: ethyl 1-(6-(2-hydroxy-3-(trifluoromethyl)phenyl)pyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate(1240970-58-4)

Safety Data

• Hazardous Substances Data: 1240970-58-4(Hazardous Substances Data)

Upstream product

• 1128268-00-7 ethyl 1-(6-chloropyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate 
• 1072944-17-2 2-hydroxy-3-(trifluoromethyl)phenylboronic acid 

Downstream Products

• 1240970-61-9 ethyl 1-{6-[2-({4-[(3S)-1-(tert-butoxycarbonyl)pyrrolidin-3-yl]benzyl}oxy)-3-(trifluoromethyl)phenyl]pyridin-2-yl}-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate 
• 1240970-62-0 ethyl 1-{6-[2-({4-[(3R)-1-(tert-butoxycarbonyl)pyrrolidin-3-yl]benzyl}oxy)-3-(trifluoromethyl)phenyl]pyridin-2-yl}-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate 
• 1240970-73-3 Ethyl 1-(6-(2-((4-(1-(tert-butoxycarbonyl)azetidin-3-yl)benzyl)oxy)-3-(trifluoromethyl)phenyl)pyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate 
• 1240967-48-9 1-(6-(2-((4-(1-(methoxycarbonyl)piperidin-4-yl)benzyl)oxy)-3-(trifluoromethyl)phenyl)pyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid 
• 1240971-10-1 C₂₆H₁₈BrF₆N₃O₃ 

Relevant articles and documents

Soluble Guanylate Cyclase Activators

This inventions relates to compounds having the structure Formula I and pharmaceutically acceptable salts thereof which are soluble guanylate cyclase activators. The compounds are useful for treatment or prevention of cardiovascular diseases, endothelial dysfunction, diastolic dysfunction, atherosclerosis, hypertension, pulmonary hypertension, angina pectoris, thromboses, restenosis, myocardial infarction, strokes, cardiac insufficiency, pulmonary hypertonia, erectile dysfunction, asthma bronchiale, chronic kidney insufficiency, diabetes, or cirrhosis of the liver.